Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.
Galan AM, Tonda R, Pino M, Reverter JC, Ordinas A, Escolar G
Transfusion 2003;43(7):885-892.
Review by
The interaction between platelets and factor VII/VIIa.
Lau HKF
Transfus Apheresis Sci 2003;28(3):279-283.
Review by Aldouri M
Successful use of recombinant factor VIIa for massive bleeding after Caesarean section due to HELLP syndrome.
Salek SZ, Sokolic V, Viskovic T, Sanjug J, Simic M, Kastelan M
Acta Haematol 2002;108(3):162-163.
Review by Aldouri M
Treatment of bleeding in severe necrotizing pancreatitis with recombinant factor Vlla.
Svartholm E, Annerhagen V, Lanne T
Anesthesiology 2002;96(6):1528.
Review by
Synthetic factor Vlla to treat dilutional coagulopathy during posterior spinal fusion in two children.
Tobias JD
Anesthesiology 2002;96(6):1522-1525.
Review by
Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device.
Potapov EV, Pasic M, Bauer M, Hetzer R
Ann Thorac Surg 2002;74(6):2182-2183.
Review by Aldouri M
Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease.
Tobias JD, Berkenbosch JW
Clin Pediatr (Phila) 2002;41(8):613-616.
Review by Aldouri M
Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors.
Konkle BA, Nelson C, Forsyth A, Hume E
Haemophilia 2002;8(5):706-710.
Review by Aldouri M
Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.
Sajdak S, Moszynski R, Opala T
Eur J Gynaecol Oncol 2002;23(4):325-326.
Review by
Treatment of critical bleeding in the future intensive care unit. [Editorial]
Goodnough LT
Intensive Care Med 2002;28(Suppl 2):S221.
Review by Aldouri M
Ongoing NovoSeven((R)) trials.
Erhardtsen E
Intensive Care Med 2002;28(Suppl 2):S248-S256.
Review by Aldouri M
Acquired inhibitor of the intrinsic pathway in a non-haemophilic patient. Control of bleeding by recombinant factor VIIa.
Lecumberri R, Panizo C, Paramo JA, Salazar MP, Rocha E
Br J Haematol 2002;119(1):284-285.
Review by Aldouri M
NovoSeven: mode of action and use in acquired haemophilia.
Von Depka M
Intensive Care Med 2002;28(Suppl 2):S222-S227.
Review by M. Aldouri
Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
Kessler C
Intensive Care Med 2002;28(Suppl 2):S228-S234.
Review by Aldouri M
Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy.
Mayer SA
Intensive Care Med 2002;28(Suppl 2):S235-S240.
Review by Aldouri M
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659